About RhyGaze
Develops gene therapies to restore sight for people with vision loss.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-A
Global Headquarters
Basel, Switzerland
Team Size
11-50
Tracked Since
Oct 1, 2026
Web & Domain Identity
Official Website
rhygaze.com
Domain Registered Date
Apr 22, 2024
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Not linked
Company Milestones & Timeline
- Capital Raise
Raised $86,000,000 · Series-A
startupintros.com
- Capital Raise
Raised $11,000,000 · Seed
startupintros.com
- Milestone
Website domain registered
rhygaze.com
Investors & Backers
ARCH Venture Partners
BioGeneration Ventures
F-Prime Capital
GV
Novartis Venture Fund
Funding History
Series-A
· Jan 10, 2025
$86,000,000 startupintros.com
Seed
· Jul 1, 2024
$11,000,000 startupintros.com
Founders & Leadership
Tracy Dowling
Chief Business Officer and General Counsel
Work email & phone locked
Unlock →
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026